Nasr Y. A. Hemdan

Nasr Y. A. Hemdan

Auto-generated profile, based on publicly available information

Nasr Y. A. Hemdan

Department of Zoology, Faculty of Science, University of Alexandria, Egypt

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSThore Santel
Thore Santel
GPGabi Pflug
Gabi Pflug
NHNasr Y. A. Hemdan
Nasr Y. A. Hemdan
ASAngelika Schäfer
Angelika Schäfer
MHMarcus Hollenbach
Marcus Hollenbach
GBGerd Birkenmeier
Gerd Birkenmeier
Glyoxalases (Glo1 and Glo2) are involved in the glycolytic pathway by detoxifying the reactive methylglyoxal (MGO) into D-lactate in a two-step reaction using glutathione (GSH) as cofactor. Inhibitors of glyoxalases are considered as anti-inflammatory and anti-carcinogenic agents. The recent finding that various polyphenols modulate Glo1 activity has prompted us to assess curcumin's potency as an Glo1 inhibitor. Cultures of whole blood cells and tumor cell lines (PC-3, JIM-1, MDA-MD 231 and 1321N1) were set up to investigate the effect of selected polyphenols, including curcumin, on the LPS-induced cytokine production (cytometric bead-based array), cell proliferation (WST-1 assay), cytosolic Glo1 and Glo2 enzymatic activity, apoptosis/necrosis (annexin V-FITC/propidium iodide staining; flow cytometric analysis) as well as GSH and ATP content. Results of enzyme kinetics revealed that curcumin, compared to the polyphenols quercetin, myricetin, kaempferol, luteolin and rutin, elicited a stronger competitive inhibitory effect on Glo1 (Ki = 5.1±1.4 µM). Applying a whole blood assay, IC50 values of pro-inflammatory cytokine release (TNF-α, IL-6, IL-8, IL-1β) were found to be positively correlated with the Ki-values of the aforementioned polyphenols. Moreover, whereas curcumin was found to hamper the growth of breast cancer (JIMT-1, MDA-MB-231), prostate cancer PC-3 and brain astrocytoma 1321N1 cells, no effect on growth or vitality of human primary hepatocytes was elucidated. Curcumin decreased D-lactate release by tumor cells, another clue for inhibition of intracellular Glo1. The results described herein provide new insights into curcumin's biological activities as they indicate that inhibition of Glo1 by curcumin may result in non-tolerable levels of MGO and GSH, which, in turn, modulate various metabolic cellular pathways including depletion of cellular ATP and GSH content. This may account for curcumin's potency as an anti-inflammatory and anti-tumor agent. The findings support the use of curcumin as a potential therapeutic agent.

1 September 2010 in Autoimmunity Reviews
Verified
Journal Article
Closed access
NHNasr Ya. Hemdan
Nasr Ya. Hemdan
GBGerd Birkenmeier
Gerd Birkenmeier
GWGunnar Wichmann
Gunnar Wichmann
AEAhmed M. Abu El-Saad
Ahmed M. Abu El-Saad
TKThorsten Krieger
Thorsten Krieger
Ulrich SackUlrich Sack
Ulrich Sack

1 June 2014 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
ATAndreas V. Thuy
Andreas V. Thuy
CRChristina-Maria Reimann
Christina-Maria Reimann
NHNasr Y. A. Hemdan
Nasr Y. A. Hemdan
MGMarkus H. Gräler
Markus H. Gräler
Sphingosine 1-phosphate (S1P) is a lipid metabolite and a ligand of five G protein-coupled cell surface receptors S1PR1 to S1PR5. These receptors are expressed on various cells and cell types of the immune, cardiovascular, respiratory, hepatic, reproductive, and neurologic systems, and S1P has an impact on many different pathophysiological conditions including autoimmune, cardiovascular, and neurodegenerative diseases, cancer, deafness, osteogenesis, and reproduction. While these diverse signalling properties of S1P have been extensively reviewed, the particular role of S1P in blood is still a matter of debate. Blood contains the highest S1P concentration of all body compartments, and several questions are still not sufficiently answered: Where does it come from and how is it metabolized? Why is the concentration of S1P in blood so high? Are minor changes of the high blood S1P concentrations physiologically relevant? Do blood cells and vascular endothelial cells that are constantly exposed to high blood S1P levels still respond to S1P via S1P receptors? Recent data reveal new insights into the functional role and the metabolic fate of blood-borne S1P. This review aims to summarize our current knowledge regarding the source, secretion, transportation, function, metabolism, and fate of S1P in blood.

1 September 2008 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MHMarcus Hollenbach
Marcus Hollenbach
AHAnja Hintersdorf
Anja Hintersdorf
KHKlaus Huse
Klaus Huse
USUlrich Sack
Ulrich Sack
MBMarina Bigl
Marina Bigl
GBGerd Birkenmeier
Gerd Birkenmeier

1 May 2006 in Toxicology
Verified
Journal Article
Closed access
NHNasr Y.A. Hemdan
Nasr Y.A. Hemdan
FEFrank Emmrich
Frank Emmrich
Ulrich SackUlrich Sack
Ulrich Sack
GWGunnar Wichmann
Gunnar Wichmann
JLJörg Lehmann
Jörg Lehmann
ILIrina Lehmann
Irina Lehmann

1 January 2012 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
CHChristian Heiss
Christian Heiss
PGParameswari Govindarajan
Parameswari Govindarajan
GSGudrun Schlewitz
Gudrun Schlewitz
NHNasr Y.A. Hemdan
Nasr Y.A. Hemdan
NSNathalie Schliefke
Nathalie Schliefke
RSReinhard Schnettler
Reinhard Schnettler
As women are the population most affected by multifactorial osteoporosis, research is focused on unraveling the underlying mechanism of osteoporosis induction in rats by combining ovariectomy (OVX) either with calcium, phosphorus, vitamin C and vitamin D2/D3 deficiency, or by administration of glucocorticoid (dexamethasone). Different skeletal sites of sham, OVX-Diet and OVX-Steroid rats were analyzed by Dual Energy X-ray Absorptiometry (DEXA) at varied time points of 0, 4 and 12 weeks to determine and compare the osteoporotic factors such as bone mineral density (BMD), bone mineral content (BMC), area, body weight and percent fat among different groups and time points. Comparative analysis and interrelationships among osteoporotic determinants by regression analysis were also determined. T scores were below-2.5 in OVX-Diet rats at 4 and 12 weeks post-OVX. OVX-diet rats revealed pronounced osteoporotic status with reduced BMD and BMC than the steroid counterparts, with the spine and pelvis as the most affected skeletal sites. Increase in percent fat was observed irrespective of the osteoporosis inducers applied. Comparative analysis and interrelationships between osteoporotic determinants that are rarely studied in animals indicate the necessity to analyze BMC and area along with BMD in obtaining meaningful information leading to proper prediction of probability of osteoporotic fractures. Enhanced osteoporotic effect observed in OVX-Diet rats indicates that estrogen dysregulation combined with diet treatment induces and enhances osteoporosis with time when compared to the steroid group. Comparative and regression analysis indicates the need to determine BMC along with BMD and area in osteoporotic determination.